OverviewSuggest Edit

X-37 is a pharmaceutical discovery and development company. It uses Atomwise’s AI platform to discover novel drug candidates by screening vast libraries of chemical compounds against high-value pharmaceutical targets. The company develops these drug candidates under an LLC structure which allows the sale or partnership of individual development programs.

HQSouth San Francisco, US


X-37 is headquartered in
South San Francisco, United States

Location Map

Latest Updates

Employees (est.) (Nov 2020)3
Cybersecurity ratingBMore

Key People/Management at X-37

Matthew Kerby

Matthew Kerby

Head of Lead Discovery
James Larrick

James Larrick

Head of Target Identification
Anie Roche

Anie Roche

General Counsel
Show more

X-37 Office Locations

X-37 has an office in South San Francisco
South San Francisco, US (HQ)
400 Oyster Point Blvd #202
Show all (1)

X-37 Financials and Metrics

Summary Metrics

X-37 total Funding

$14.5 m

X-37 latest funding size

$14.50 m

Time since last funding

a year ago

X-37 investors

X-37's latest funding round in November 2019 was reported to be $14.5 m. In total, X-37 has raised $14.5 m
Show all financial metrics

X-37 Cybersecurity Score

Cybersecurity ratingPremium dataset



SecurityScorecard logo

X-37 Online and Social Media Presence

Embed Graph

X-37 Frequently Asked Questions

  • Who are X-37 key executives?

    X-37's key executives are Matthew Kerby, James Larrick and Anie Roche.

  • How many employees does X-37 have?

    X-37 has 3 employees.

  • Who are X-37 competitors?

    Competitors of X-37 include Vitality Biopharma, Opiant Pharmaceuticals and Medizone International.

  • Where is X-37 headquarters?

    X-37 headquarters is located at 400 Oyster Point Blvd #202, South San Francisco.

  • Where are X-37 offices?

    X-37 has an office in South San Francisco.

  • How many offices does X-37 have?

    X-37 has 1 office.